PureTech Health plc - American Depositary Shares — Cash Flow (NASDAQ:PRTC) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 131.83 M158.27 M178.79 M105.92 M134.37 M — Cash from investing activities 364.48 M197.38 M107.22 M68.99 M240.89 M — Cash from financing activities 38.87 M22.73 M29.83 M78.14 M16.96 M — Free cash flow 131.83 M158.27 M178.79 M105.92 M134.37 M —

PureTech Health plc - American Depositary Shares

PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.

Haberler

Deupirfenidone, nadir akciğer hastalığı için yetim ilaç statüsü aldı

Deupirfenidone receives orphan drug status for rare lung disease

PureTech’in deupirfenidone ilacı IPF için FDA ve AB’den yetim ilaç statüsü aldı

PureTech’s deupirfenidone receives FDA and EU orphan drug status for IPF

PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

PureTech CEO’su J.P. Morgan Sağlık Konferansı’nda sunum yapacak

PureTech CEO to present at J.P. Morgan Healthcare Conference

PureTech Health, Robert Lyne’ı kalıcı CEO olarak atadı

PureTech Health appoints Robert Lyne as permanent CEO

PureTech, hissedar endişelerinin ardından Genel Kurul sonuçları hakkında bilgi verdi

PureTech provides update on AGM results following shareholder concerns

PureTech hissesi, IPF ilacı hakkındaki FDA toplantısı sonrası düştü